380 related articles for article (PubMed ID: 23482447)
1. CD40 deficiency in mice exacerbates obesity-induced adipose tissue inflammation, hepatic steatosis, and insulin resistance.
Guo CA; Kogan S; Amano SU; Wang M; Dagdeviren S; Friedline RH; Aouadi M; Kim JK; Czech MP
Am J Physiol Endocrinol Metab; 2013 May; 304(9):E951-63. PubMed ID: 23482447
[TBL] [Abstract][Full Text] [Related]
2. Mesenteric Fat Lipolysis Mediates Obesity-Associated Hepatic Steatosis and Insulin Resistance.
Wueest S; Item F; Lucchini FC; Challa TD; Müller W; Blüher M; Konrad D
Diabetes; 2016 Jan; 65(1):140-8. PubMed ID: 26384383
[TBL] [Abstract][Full Text] [Related]
3. Adipose tissue inflammation contributes to short-term high-fat diet-induced hepatic insulin resistance.
Wiedemann MS; Wueest S; Item F; Schoenle EJ; Konrad D
Am J Physiol Endocrinol Metab; 2013 Aug; 305(3):E388-95. PubMed ID: 23736545
[TBL] [Abstract][Full Text] [Related]
4. Osteopontin deletion prevents the development of obesity and hepatic steatosis via impaired adipose tissue matrix remodeling and reduced inflammation and fibrosis in adipose tissue and liver in mice.
Lancha A; Rodríguez A; Catalán V; Becerril S; Sáinz N; Ramírez B; Burrell MA; Salvador J; Frühbeck G; Gómez-Ambrosi J
PLoS One; 2014; 9(5):e98398. PubMed ID: 24871103
[TBL] [Abstract][Full Text] [Related]
5. Myeloid-specific deletion of Zfp36 protects against insulin resistance and fatty liver in diet-induced obese mice.
Caracciolo V; Young J; Gonzales D; Ni Y; Flowers SJ; Summer R; Waldman SA; Kim JK; Jung DY; Noh HL; Kim T; Blackshear PJ; O'Connell D; Bauer RC; Kallen CB
Am J Physiol Endocrinol Metab; 2018 Oct; 315(4):E676-E693. PubMed ID: 29509432
[TBL] [Abstract][Full Text] [Related]
6. Macrophage CD40 plays a minor role in obesity-induced metabolic dysfunction.
Aarts SABM; Reiche ME; den Toom M; Beckers L; Gijbels MJJ; Gerdes N; de Winther MPJ; Lutgens E
PLoS One; 2018; 13(8):e0202150. PubMed ID: 30096208
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of Gastric Inhibitory Polypeptide Receptor Signaling in Adipose Tissue Reduces Insulin Resistance and Hepatic Steatosis in High-Fat Diet-Fed Mice.
Joo E; Harada N; Yamane S; Fukushima T; Taura D; Iwasaki K; Sankoda A; Shibue K; Harada T; Suzuki K; Hamasaki A; Inagaki N
Diabetes; 2017 Apr; 66(4):868-879. PubMed ID: 28096257
[TBL] [Abstract][Full Text] [Related]
8. Interleukin-1β regulates fat-liver crosstalk in obesity by auto-paracrine modulation of adipose tissue inflammation and expandability.
Nov O; Shapiro H; Ovadia H; Tarnovscki T; Dvir I; Shemesh E; Kovsan J; Shelef I; Carmi Y; Voronov E; Apte RN; Lewis E; Haim Y; Konrad D; Bashan N; Rudich A
PLoS One; 2013; 8(1):e53626. PubMed ID: 23341960
[TBL] [Abstract][Full Text] [Related]
9. CD40L deficiency ameliorates adipose tissue inflammation and metabolic manifestations of obesity in mice.
Poggi M; Engel D; Christ A; Beckers L; Wijnands E; Boon L; Driessen A; Cleutjens J; Weber C; Gerdes N; Lutgens E
Arterioscler Thromb Vasc Biol; 2011 Oct; 31(10):2251-60. PubMed ID: 21817098
[TBL] [Abstract][Full Text] [Related]
10. CD40 promotes MHC class II expression on adipose tissue macrophages and regulates adipose tissue CD4+ T cells with obesity.
Morris DL; Oatmen KE; Mergian TA; Cho KW; DelProposto JL; Singer K; Evans-Molina C; O'Rourke RW; Lumeng CN
J Leukoc Biol; 2016 Jun; 99(6):1107-19. PubMed ID: 26658005
[TBL] [Abstract][Full Text] [Related]
11. Impact of Reduced ATGL-Mediated Adipocyte Lipolysis on Obesity-Associated Insulin Resistance and Inflammation in Male Mice.
Schoiswohl G; Stefanovic-Racic M; Menke MN; Wills RC; Surlow BA; Basantani MK; Sitnick MT; Cai L; Yazbeck CF; Stolz DB; Pulinilkunnil T; O'Doherty RM; Kershaw EE
Endocrinology; 2015 Oct; 156(10):3610-24. PubMed ID: 26196542
[TBL] [Abstract][Full Text] [Related]
12. Coinhibitory suppression of T cell activation by CD40 protects against obesity and adipose tissue inflammation in mice.
Wolf D; Jehle F; Michel NA; Bukosza EN; Rivera J; Chen YC; Hoppe N; Dufner B; Rodriguez AO; Colberg C; Nieto L; Rupprecht B; Wiedemann A; Schulte L; Peikert A; Bassler N; Lozhkin A; Hergeth SP; Stachon P; Hilgendorf I; Willecke F; von Zur Mühlen C; von Elverfeldt D; Binder CJ; Aichele P; Varo N; Febbraio MA; Libby P; Bode C; Peter K; Zirlik A
Circulation; 2014 Jun; 129(23):2414-25. PubMed ID: 24664276
[TBL] [Abstract][Full Text] [Related]
13. Blocking CD40-TRAF6 signaling is a therapeutic target in obesity-associated insulin resistance.
Chatzigeorgiou A; Seijkens T; Zarzycka B; Engel D; Poggi M; van den Berg S; van den Berg S; Soehnlein O; Winkels H; Beckers L; Lievens D; Driessen A; Kusters P; Biessen E; Garcia-Martin R; Klotzsche-von Ameln A; Gijbels M; Noelle R; Boon L; Hackeng T; Schulte KM; Xu A; Vriend G; Nabuurs S; Chung KJ; Willems van Dijk K; Rensen PC; Gerdes N; de Winther M; Block NL; Schally AV; Weber C; Bornstein SR; Nicolaes G; Chavakis T; Lutgens E
Proc Natl Acad Sci U S A; 2014 Feb; 111(7):2686-91. PubMed ID: 24492375
[TBL] [Abstract][Full Text] [Related]
14. Dietary capsaicin reduces obesity-induced insulin resistance and hepatic steatosis in obese mice fed a high-fat diet.
Kang JH; Goto T; Han IS; Kawada T; Kim YM; Yu R
Obesity (Silver Spring); 2010 Apr; 18(4):780-7. PubMed ID: 19798065
[TBL] [Abstract][Full Text] [Related]
15. CD40L deficiency attenuates diet-induced adipose tissue inflammation by impairing immune cell accumulation and production of pathogenic IgG-antibodies.
Wolf D; Jehle F; Ortiz Rodriguez A; Dufner B; Hoppe N; Colberg C; Lozhkin A; Bassler N; Rupprecht B; Wiedemann A; Hilgendorf I; Stachon P; Willecke F; Febbraio M; von zur Muhlen C; Binder CJ; Bode C; Zirlik A; Peter K
PLoS One; 2012; 7(3):e33026. PubMed ID: 22412980
[TBL] [Abstract][Full Text] [Related]
16. Deficiency of T cell CD40L has minor beneficial effects on obesity-induced metabolic dysfunction.
Reiche ME; den Toom M; Willemsen L; van Os B; Gijbels MJJ; Gerdes N; Aarts SABM; Lutgens E
BMJ Open Diabetes Res Care; 2019; 7(1):e000829. PubMed ID: 31908798
[TBL] [Abstract][Full Text] [Related]
17. Loss of regulator of G protein signaling 5 exacerbates obesity, hepatic steatosis, inflammation and insulin resistance.
Deng W; Wang X; Xiao J; Chen K; Zhou H; Shen D; Li H; Tang Q
PLoS One; 2012; 7(1):e30256. PubMed ID: 22272317
[TBL] [Abstract][Full Text] [Related]
18. Programmed cell death-4 deficiency prevents diet-induced obesity, adipose tissue inflammation, and insulin resistance.
Wang Q; Dong Z; Liu X; Song X; Song Q; Shang Q; Jiang Y; Guo C; Zhang L
Diabetes; 2013 Dec; 62(12):4132-43. PubMed ID: 23990362
[TBL] [Abstract][Full Text] [Related]
19. Myonectin deletion promotes adipose fat storage and reduces liver steatosis.
Little HC; Rodriguez S; Lei X; Tan SY; Stewart AN; Sahagun A; Sarver DC; Wong GW
FASEB J; 2019 Jul; 33(7):8666-8687. PubMed ID: 31002535
[TBL] [Abstract][Full Text] [Related]
20. Genetic inactivation of the LIGHT (TNFSF14) cytokine in mice restores glucose homeostasis and diminishes hepatic steatosis.
Herrero-Cervera A; Vinué Á; Burks DJ; González-Navarro H
Diabetologia; 2019 Nov; 62(11):2143-2157. PubMed ID: 31388695
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
